In October 2024, the below number of individuals have been recruited in Swedegene. DNA and clinical data collection for these are completed.

ADR type	Number
Angioedema	540
Anaphylaxis	148
Urticaria	201
Other allergic reactions	127
Cough related to ACE-inhibitors	148
Osteonecrosis and atypical fractures due to bisphosphonates	144
Phototoxic reactions (mainly due to topical NSAIDs)	51
Blood cell dyscrasia (agranulocytosis, thrombocytopenia and anemia) to non-cytostatic drugs	302
Metabolic reactions from neuroleptics and antidepressants (mainly weight gain)	72
Hyponatremia/SIADH due to antidepressants and antiepileptics	41
CNS toxicity and neuropsychiatric reactions from antiviral therapy and antibiotics	95
Stevens-Johnson syndrome/Toxic epidermal necrolysis	67
Tendon-rupture from flouroquinolones	33
Liver toxicity	469
Rhabdomyolysis related to statins/fibrates	52
Torsade de Pointes/QT-prolongation	24
Narcolepsy associated with Pandemrix	85
Hypersomnia associated with Pandemrix	14
Pancreatitis	101
Alopecia	27
Bleedings from new oral anticoagulants (NOACs)	160
Lack of efficacy of NOACs	33
Pneumonitis	44
Renal toxicity	103
Ankle oedema from calcium channel blockers	46
Gingival hyperplasia from calcium channel blockers	17
Adverse reactions to Covid-19 vaccines	881
Thyroiditis	18
Gastrointestinal reactions to medication for Parkinson’s disease	2
Controls	568
Total number of cases	4613

ACE = angiotensin converting enzyme; NSAID = non-steroidal anti-inflammatory drug; NOAC=non-vitamin K oral anticoagulant drug.

Note that the number of cases for a particular ADR may be greater than the total number of cases as some individuals have experienced multiple ADRs concomitantly.